Imago BioSciences

YTD

ALL

Why Robinhood?

You can watch IMGO and buy or sell other stocks, ETFs, and their options commission-free!

About IMGO

Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians.

CEO

Hugh Young Rienhoff, Jr., MD

CEOHugh Young Rienhoff, Jr., MD

Employees

—

Employees—

Headquarters

Redwood City, California

HeadquartersRedwood City, California

Founded

2012

Founded2012

Employees

—

Employees—

IMGO Key Statistics

Market cap

1.22B

Market cap1.22B

Price-Earnings ratio

-19.67

Price-Earnings ratio-19.67

Dividend yield

—

Dividend yield—

Average volume

149.88K

Average volume149.88K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$36.09

52 Week high$36.09

52 Week low

$11.56

52 Week low$11.56

People also own

Based on the portfolios of people who own IMGO. This list is generated using Robinhood data, and it’s not a recommendation.